STAT3 and cholangiocarcinoma: Increased HB-EGF secretion in HLMFs, which upregulate α-SMA, markedly increases tumor formation of CC cells and tumor invasion in vivo by EGFR activation-mediated upregulation of PECAM-1 and activation of STAT3/ERK.